HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsunari Nakajima Selected Research

aurapten

3/2020Citrus Auraptene Induces Expression of Brain-Derived Neurotrophic Factor in Neuro2a Cells.
1/2020[Neuroprotective effects of the peel of Citrus kawachiensis (Kawachi Bankan) and auraptene in the hippocampus of hyperglycemia mice and global cerebral ischemia/reperfusion injury mice].
12/2019Citrus Auraptene Induces Glial Cell Line-Derived Neurotrophic Factor in C6 Cells.
1/2019Auraptene/Naringin-Rich Fruit Juice of Citrus kawachiensis (Kawachi Bankan) Prevents Ischemia-Induced Neuronal Cell Death in Mouse Brain through Anti-Inflammatory Responses.
1/2019Continual Treatment with the Peels of Citrus kawachiensis (Kawachi Bankan) Protects against Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson's Disease.
8/2018Inhibitory Effects of Auraptene and Naringin on Astroglial Activation, Tau Hyperphosphorylation, and Suppression of Neurogenesis in the Hippocampus of Streptozotocin-Induced Hyperglycemic Mice.
10/2016Auraptene and Other Prenyloxyphenylpropanoids Suppress Microglial Activation and Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson's Disease.
1/2016Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination.
1/2014Auraptene in the Peels of Citrus kawachiensis (Kawachi Bankan) Ameliorates Lipopolysaccharide-Induced Inflammation in the Mouse Brain.
1/2013Anti-inflammatory and neuroprotective effects of auraptene, a citrus coumarin, following cerebral global ischemia in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsunari Nakajima Research Topics

Disease

10Inflammation (Inflammations)
01/2021 - 05/2013
8Ischemia
01/2021 - 10/2012
7Alzheimer Disease (Alzheimer's Disease)
08/2019 - 06/2003
6Brain Ischemia (Cerebral Ischemia)
01/2021 - 10/2012
4Body Weight (Weight, Body)
10/2017 - 01/2014
3Glioma (Gliomas)
03/2020 - 08/2019
3Hyperglycemia
01/2020 - 08/2018
3Parkinson Disease (Parkinson's Disease)
08/2019 - 10/2016
2Reperfusion Injury
01/2020 - 07/2018
2Demyelinating Diseases (Demyelinating Disease)
01/2016 - 11/2013
1Neoplasms (Cancer)
05/2021
1Infections
05/2021
1Cognitive Dysfunction
01/2021
1Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1Neuroblastoma
03/2020
1Brain Diseases (Brain Disorder)
12/2019
1Central Nervous System Diseases (CNS Diseases)
08/2019
1Epilepsy (Aura)
08/2019
1Chronic Pain
08/2019
1Brain Injuries (Brain Injury)
04/2019
1Mental Disorders (Mental Disorder)
12/2016
1Memory Disorders (Memory Loss)
04/2015
1Stroke (Strokes)
04/2015
1Multiple Sclerosis
11/2013
1Neuromyelitis Optica (Devic's Disease)
11/2013
1Neuroinflammatory Diseases
05/2013
1Hydrocephalus (Hydrocephaly)
03/2011
1Seizures (Absence Seizure)
08/2002
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2002

Drug/Important Bio-Agent (IBA)

10auraptenIBA
03/2020 - 01/2013
8Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 10/2012
7Neuroprotective AgentsIBA
03/2020 - 01/2013
7LipopolysaccharidesIBA
01/2019 - 05/2013
6Proteins (Proteins, Gene)FDA Link
03/2020 - 12/2006
6Presenilin-1IBA
03/2011 - 06/2003
5PowdersIBA
01/2020 - 01/2014
4FlavonoidsIBA
01/2021 - 10/2012
4Messenger RNA (mRNA)IBA
03/2020 - 11/2013
43,3',4',5,6,7,8-heptamethoxyflavoneIBA
04/2016 - 10/2012
3Streptozocin (Streptozotocin)FDA Link
01/2020 - 08/2018
3naringinIBA
01/2019 - 07/2018
3Calcium-Calmodulin-Dependent Protein KinasesIBA
07/2018 - 04/2015
2oenothein BIBA
05/2021 - 05/2013
2Nerve Growth Factors (Neurotrophins)IBA
01/2021 - 10/2012
2Phosphotransferases (Kinase)IBA
03/2020 - 10/2017
2Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
03/2020 - 10/2012
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
03/2020 - 12/2019
2coumarinIBA
12/2019 - 01/2013
2CuprizoneIBA
01/2016 - 11/2013
1ellagitanninIBA
05/2021
1Ointments (Pastes)IBA
01/2021
1glansreginin AIBA
01/2020
1Glutathione (Reduced Glutathione)IBA
07/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2018
1U 0126 (UO 126)IBA
10/2017
1MitogensIBA
10/2017
1Cholinergic Agents (Cholinergics)IBA
12/2016
1CorticosteroneIBA
04/2016
1flavoneIBA
04/2015
1FlavonesIBA
04/2015
1EdaravoneIBA
04/2015
1AntioxidantsIBA
04/2015
1Pharmaceutical PreparationsIBA
04/2015
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2014
1Chelating AgentsIBA
11/2013
1CopperIBA
11/2013
1AutoantibodiesIBA
11/2013
1Kcnj10 (channel)IBA
11/2013
1Aquaporins (Water Channels)IBA
11/2013
1Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA
11/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2013
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2012
1Glial Fibrillary Acidic ProteinIBA
10/2012
1Intermediate Filament ProteinsIBA
10/2012
1Indicators and Reagents (Reagents)IBA
08/2002
1Isoaspartic Acid (Isoaspartate)IBA
08/2002

Therapy/Procedure

1Therapeutics
04/2019
1Oral Administration
10/2017